PRO Therapeutics develops an off‑the‑shelf graft that acts as a cellular underlayment to promote the regeneration of soft tissue—such as tendons, ligaments, and muscles—into bone. The product integrates with standard rotator cuff repair procedures, enhancing tendon‑to‑bone adhesion and aiming to reduce post‑surgical re‑tear rates while restoring native mechanical function.
Funding
Funding not disclosed
Founders
Product
Problem
Rotator cuff and other tendon, ligament, and muscle injuries have high re‑tear rates after surgical repair, leading to costly repeat procedures and prolonged loss of function, especially in patients over 60.
Solution
PRO Therapeutics offers an off‑the‑shelf graft that serves as a cellular underlayment to promote the regeneration of soft tissue into bone. The graft encourages migration of bone‑derived cells into the tendon repair site, enhancing biological healing and restoring native biomechanics. It is designed for seamless integration with existing surgical techniques, requiring minimal changes to the operative workflow. By improving tendon‑to‑bone adhesion, the product aims to substantially lower post‑operative re‑tear rates and the associated clinical and economic burden.
Target Audience
Primary customers are orthopedic surgeons and sports medicine specialists performing tendon, ligament, and muscle repairs, as well as hospitals and surgical centers seeking to improve outcomes for rotator cuff and related soft‑tissue surgeries.
Features
- Off‑the‑shelf, ready‑to‑use graft material eliminating the need for patient‑specific manufacturing
- Cellular underlayment that facilitates bone‑to‑tendon cell migration and tissue integration
- Compatible with standard rotator cuff repair procedures with no major workflow modifications
- Engineered to restore native mechanical function of repaired tendons, ligaments, and muscles
- Scalable platform applicable to a range of soft‑tissue injuries beyond the rotator cuff